Digital Pathology Market by Product, Type, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580615
  • Report
  • Region: Global
  • 252 pages
  • Allied Analytics LLP
1 of 4
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digitalization of pathology has led to the automation of tests during disease diagnosis among other applications. For instance, a single digital instrument can perform tests that were previously carried out using five instruments by pathologists. Digital pathology solutions offer scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.

Efficient cost of digital pathology products, ease of virtual transportation of slides, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. In addition, higher adoption of digital pathology as compared to conventional pathology diagnosis drives the market growth. On the other hand, barriers such as unclear reimbursement policies, dearth of skilled personnel, and unwillingness of older pathologists to adopt to new technology restrain the market growth. However, rise in initiatives towards commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.

The global digital pathology market is segmented on the basis of product, type, end user, and region. Based on product, the market is categorized into whole slide imaging, image analysis informatics, information management system storage & communication, digital IVD devices, and others (telepathology). By type, it is classified into automated hematology analyzers & blood cell counters, chromosome analyzers, FISH enumeration systems, urine sediment analyzers, immunohistochemistry image analysis applications, digital cytopathology, digital PCR, signet cell detection, and digital holographic microscopy. Depending on end user, it is fragmented into educational, clinical, pharma & biotech companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global digital pathology market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of digital pathology used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Product

Whole Slide Imaging
Image Analysis Informatics
Information Management System Storage & Communication
Digital IVD Devices
Others (Telepathology)

By Type

Automated Hematology Analyzers & Blood Cell Counters
Chromosome Analyzers
Fish Enumeration Systems
Urine Sediment Analyzers
Immunohistochemistry Image Analysis Applications
Digital Cytopathology
Digital PCR
Signet Cell Detection
Digital Holographic Microscopy

By End User

Educational
Clinical
Pharma & Biotech Companies

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Rest of LAMEA

KEY PLAYERS PROFILED

Danaher Corporation
Digipath Inc.
Glencoe Software, Inc.
Hamamatsu Photonics K.K.
Indica Labs, Inc.
Koninklijke Philips N.V.
Nikon Corporation
PerkinElmer, Inc.
Pixcelldata Ltd.
Visiopharm A/S

The other players in the value chain include (profiles not included in the report)

Leica Biosystems
Ventana Medical Systems
3DHISTECH
HCL Technologies
Pathology Devices, Inc.
Biogeniux
OptraSCAN
Pathcore
Sectra
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Use of digital pathology in disease diagnosis
3.5.1.2. Growing trend of digitalization in medical sector
3.5.1.3. Ease of consultation
3.5.1.4. Diagnosis in remote regions
3.5.2. Restraints
3.5.2.1. Lack in reimbursement
3.5.2.2. High cost of digital pathology solutions
3.5.3. Opportunity
3.5.3.1. Increasing potential of digital pathology

CHAPTER 4: DIGITAL PATHOLOGY MARKET BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Whole Slide Imaging
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Image Analysis-Informatics
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Information Management System Storage & Communication
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Digital IVD Devices
4.5.1. Key trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Other (Telepathology)
4.6.1. Key trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

CHAPTER 5: DIGITAL PATHOLOGY MARKET BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Automated Hematology Analyzers And Blood Cell Counters
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Chromosome Analyzers
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. FISH Enumeration Systems
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Urine Sediment Analyzers
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Immunohistochemistry Image Analysis Applications
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Digital Cytopathology
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Digital PCR
5.8.1. Market size and forecast
5.8.2. Market analysis, by country
5.9. Signet Cell Detection
5.9.1. Market size and forecast
5.9.2. Market analysis, by country
5.10. Digital Holographic Microscopy
5.10.1. Market size and forecast
5.10.2. Market analysis, by country

CHAPTER 6: DIGITAL PATHOLOGY MARKET BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Educational
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Clinical
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Pharma & Biotech Companies
6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: DIGITAL PATHOLOGY MARKET BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America market size & forecast for digital pathology market by country
7.2.3. North America market size & forecast for digital pathology market by product
7.2.4. North America market size & forecast for digital pathology market by type
7.2.5. North America market size & forecast for digital pathology market by end user
7.2.5.1. U.S. market size & forecast for digital pathology market by product
7.2.5.2. U.S. market size & forecast for digital pathology market by type
7.2.5.3. U.S. market size & forecast for digital pathology market by end user
7.2.5.4. Canada market size & forecast for digital pathology market by product
7.2.5.5. Canada market size & forecast for digital pathology market by type
7.2.5.6. Canada market size & forecast for digital pathology market by end user
7.2.5.7. Mexico market size & forecast for digital pathology market by product
7.2.5.8. Mexico market size & forecast for digital pathology market by type
7.2.5.9. Mexico market size & forecast for digital pathology market by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size & forecast for digital pathology market by country
7.3.3. Europe market size & forecast for digital pathology market by product
7.3.4. Europe market size & forecast for digital pathology market by type
7.3.5. Europe market size & forecast for digital pathology market by end user
7.3.5.1. Germany market size & forecast for digital pathology market by product
7.3.5.2. Germany market size & forecast for digital pathology market by type
7.3.5.3. Germany market size & forecast for digital pathology market by end user
7.3.5.4. France market size & forecast for digital pathology market by product
7.3.5.5. France market size & forecast for digital pathology market by type
7.3.5.6. France market size & forecast for digital pathology market by end user
7.3.5.7. UK market size & forecast for digital pathology market by product
7.3.5.8. UK market size & forecast for digital pathology market by type
7.3.5.9. UK market size & forecast for digital pathology market by end user
7.3.5.10. Italy market size & forecast for digital pathology market by product
7.3.5.11. Italy market size & forecast for digital pathology market by type
7.3.5.12. Italy market size & forecast for digital pathology market by end user
7.3.5.13. Spain market size & forecast for digital pathology market by product
7.3.5.14. Spain market size & forecast for digital pathology market by type
7.3.5.15. Spain market size & forecast for digital pathology market by end user
7.3.5.16. Russia market size & forecast for digital pathology market by product
7.3.5.17. Russia market size & forecast for digital pathology market by type
7.3.5.18. Russia market size & forecast for digital pathology market by end user
7.3.5.19. Rest of Europe market size & forecast for digital pathology market by product
7.3.5.20. Rest of Europe market size & forecast for digital pathology market by type
7.3.5.21. Rest of Europe market size & forecast for digital pathology market by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size & forecast for digital pathology market by country
7.4.3. Asia-Pacific market size & forecast for digital pathology market by product
7.4.4. Asia-Pacific market size & forecast for digital pathology market by type
7.4.5. Asia-Pacific market size & forecast for digital pathology market by end user
7.4.5.1. Japan market size & forecast for digital pathology market by product
7.4.5.2. Japan market size & forecast for digital pathology market by type
7.4.5.3. Japan market size & forecast for digital pathology market by end user
7.4.5.4. China market size & forecast for digital pathology market by product
7.4.5.5. China market size & forecast for digital pathology market by type
7.4.5.6. China market size & forecast for digital pathology market by end user
7.4.5.7. Australia market size & forecast for digital pathology market by product
7.4.5.8. Australia market size & forecast for digital pathology market by type
7.4.5.9. Australia market size & forecast for digital pathology market by end user
7.4.5.10. India market size & forecast for digital pathology market by product
7.4.5.11. India market size & forecast for digital pathology market by type
7.4.5.12. India market size & forecast for digital pathology market by end user
7.4.5.13. South Korea market size & forecast for digital pathology market by product
7.4.5.14. South Korea market size & forecast for digital pathology market by type
7.4.5.15. South Korea market size & forecast for digital pathology market by end user
7.4.5.16. Taiwan market size & forecast for digital pathology market by product
7.4.5.17. Taiwan market size & forecast for digital pathology market by type
7.4.5.18. Taiwan market size & forecast for digital pathology market by end user
7.4.5.19. Rest of Asia-Pacific market size & forecast for digital pathology market by product
7.4.5.20. Rest of Asia-Pacific market size & forecast for digital pathology market by type
7.4.5.21. Rest of Asia-Pacific market size & forecast for digital pathology market by end user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. LAMEA market size & forecast for digital pathology market by country
7.5.3. LAMEA market size & forecast for digital pathology market by product
7.5.4. LAMEA market size & forecast for digital pathology market by type
7.5.5. LAMEA market size & forecast for digital pathology market by end user
7.5.5.1. Brazil market size & forecast for digital pathology market by product
7.5.5.2. Brazil market size & forecast for digital pathology market by type
7.5.5.3. Brazil market size & forecast for digital pathology market by end user
7.5.5.4. Turkey market size & forecast for digital pathology market by product
7.5.5.5. Turkey market size & forecast for digital pathology market by type
7.5.5.6. Turkey market size & forecast for digital pathology market by end user
7.5.5.7. Venezuela market size & forecast for digital pathology market by product
7.5.5.8. Venezuela market size & forecast for digital pathology market by type
7.5.5.9. Venezuela market size & forecast for digital pathology market by end user
7.5.5.10. Saudi Arabia market size & forecast for digital pathology market by product
7.5.5.11. Saudi Arabia market size & forecast for digital pathology market by type
7.5.5.12. Saudi Arabia market size & forecast for digital pathology market by end user
7.5.5.13. Rest of LAMEA market size & forecast for digital pathology market by product
7.5.5.14. Rest of LAMEA market size & forecast for digital pathology market by type
7.5.5.15. Rest of LAMEA market size & forecast for digital pathology market by end user
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Digital Pathology Market by Product, Type, and End Userlobal Opportunity Analysis and Industry Forecast, 2017-2023," the global digital pathology market was valued at $3,323 million in 2016, and is projected to reach $8,668 million by 2023, growing at a CAGR of 14.8% from 2017 to 2023. The digital IVD devices segment accounted for about seventh-eighths share of the global market in 2016.

Digital pathology (DP) is an emerging technology in the field of pathology, where test results are converted into digital images for easy viewing, analysis, storage, and management of the data collected. This is expected to result in many advancements and upgradation of conventional pathology. Thus, lack in number of pathologists globally is addressed by the use of digital pathology, which is the major benefit of this technology. In addition, increase in applications of digital pathology for disease consultation, especially for cancer, boosts the market growth. The other key factors contributing to the growth of this market are rise in prevalence of chronic diseases and ease in virtual transportation of slides. However, lack of reimbursement policies, inadequate infrastructure, and high cost of digital pathology devices restrict the growth of the market.

Image analysis informatics is expected to register a significant growth rate during the forecast period, owing to the benefits offered by image analysis informatics such as it aids in analyzing multitude of images with ease and in studying complex morphologies & features Moreover, it enables comparison of data with other related data for obtaining better decisions, which fuels the growth of the image analysis informatics segment.

Automated hematology analyzers & blood cell counters dominated the market in 2016, as cell counting with these devices is rapid. Moreover, they improve the accuracy test results, eliminate chances of errors, reduce inter operator variability, and minimize the potential contact with samples. In addition, automated hematology analyzers & blood cell counters are relatively cost-efficient and can process up to 120150 samples per hour.

Among the end users, the clinics segment accounted for the largest share in the global digital pathology market, as clinics deliver well-organized, documented, retrieved, and logistical pathological procedures. Thus, rise in number of clinics incorporating digital pathology over traditional pathology augments the market growth.

Key Findings of the Digital Pathology Market

Digital holographic microscopy segment accounted for about one-fourth share of the total market in 2016, and is expected to register a CAGR of 11.5% from 2017 to 2023.
The chromosome analyzers segment is expected to grow at a CAGR of 17.9% during the forecast period.
The U.S. dominated the North American digital pathology market, and is projected to grow at a CAGR of 12.5% from 2017 to 2023.
Pharma & biotech companies accounted for three-eighths share of the total market, and is estimated to grow with a high CAGR of 16.6% during the forecast period.
India is expected to register the highest growth rate in the Asia-Pacific region during the forecast period.

Asia-Pacific is expected to witness highest growth rate in the global market, and is expected to continue this trend throughout the forecast period. This is attributed to high population density and rise in incidence of chronic diseases across high populous countries such as India and China. For instance, the number of annual deaths has reached 56 million individuals in 2015, and 70% of the global deaths in 2015 were due to noncommunicable diseases such as Alzheimer's disease, ischemic heart disease, diabetes, chronic kidney disease, stroke, and other dementias.

The key players operating in the global digital pathology market are Danaher Corporation, Digipath Inc., Glencoe Software, Inc., Hamamatsu Photonics K.K., Indica Labs, Inc., Koninklijke Philips N.V., Nikon Corporation, PerkinElmer, Inc., Pixcelldata Ltd., and Visiopharm A/S. Other players operating in the value chain are Leica Biosystems, Ventana Medical Systems, 3DHISTECH, HCL Technologies, Pathology Devices, Inc., Biogeniux, OptraSCAN, Pathcore, and Sectrae.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll